VIP (1 - 12), human, porcine, rat
CAS No. 120928-03-2
VIP (1 - 12), human, porcine, rat( ——— )
Catalog No. M41759 CAS No. 120928-03-2
VIP (1-12), human, porcine, rat, ovine is a vasoactive intestinal peptide (VIP) fragment. VIP (1-12), human, porcine, rat, ovine is a ligand for the CD4 (T4)/human immunodeficiency virus receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameVIP (1 - 12), human, porcine, rat
-
NoteResearch use only, not for human use.
-
Brief DescriptionVIP (1-12), human, porcine, rat, ovine is a vasoactive intestinal peptide (VIP) fragment. VIP (1-12), human, porcine, rat, ovine is a ligand for the CD4 (T4)/human immunodeficiency virus receptor.
-
DescriptionVIP (1-12), human, porcine, rat, ovine is a vasoactive intestinal peptide (VIP) fragment. VIP (1-12), human, porcine, rat, ovine is a ligand for the CD4 (T4)/human immunodeficiency virus receptor.
-
In Vitro———
-
In VivoAnimal Model:Male Wistar rats (250 g) Dosage:1, 2.5, 5, 10 μg Administration:Intracerebroventrical injection Result:Caused a dose-dependent decrease in the response.
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number120928-03-2
-
Formula Weight1425.49
-
Molecular FormulaC61H88N18O22
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Takashima A, et, al. Vasoactive intestinal peptide (VIP) causes memory impairment in passive avoidance responding of the rat. Peptides. 1993 Oct;14(5):1067-71.
molnova catalog
related products
-
Inebilizumab
Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells.
-
Niraparib Tosylate M...
Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.
-
urolithin M6
urolithin M6 (UM6) is an ellagitannin metabolite produced by gut microbiota, was identified as a putative galloflavin mimetic
Cart
sales@molnova.com